PATENT CLAIM ANALYSIS

Application Number: 16069487
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.

Claim (Index 64):
The method of  claim 44 , wherein the antibody or fragment thereof comprises a light chain variable region comprising an amino acid sequence selected from the group consisting of SEQ ID NO:239, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, and 338.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.17143
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15166305', '15254315', '15636610', '14472116', '15211504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6740211100000842
- 35 USC 102 Novelty (BERT): 0.543539965041666
- Combined Prediction Score: 0.6609729955042425
- Mean Citation Score: 363.044838
- Max Citation Score: 381.17462
- Similarity Product: 306.9593524737084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test